Gyros Protein Technologies and Cygnus Technologies have signed a licensing and supply agreement.
 
Under the agreement, Cygnus Technologies will supply Gyros Protein Technologies with its proprietary reagents for host cell protein analysis, enabling the development of new Gyrolab® immunoassay kits and applications to further support customers working in biotherapeutics development and manufacturing.  Gyrolab users carrying out impurity analysis will now also benefit from the products and expertise provided by Cygnus Technologies. 
 
Cygnus Technologies will also assist Gyrolab users in developing custom, process-specific antibodies, or in running orthogonal methods for antibody and impurity characterization.
 
Dan Calvo, chief executive officer and president, Gyros Protein Technologies, said, “The agreement with Cygnus Technologies forms part of our strategy to continue to support customers with high quality bioanalytical solutions, and to increase productivity in the development and manufacturing of biotherapeutics. Cygnus Technologies’ offering complements our current portfolio, and the partnership will enable us to increase our support to bioprocess customers.”